uk semaglutide health regulator approves higher dose of Novo's Wegovy for obesity patients Semaglutide 30mg (Sema) UK —

In clinical trials, approximately 60% of patients report significant symptom reduction by week four

For more on screening and support in that area, see Ozempic and Eating Disorders

However, because GLP-1s reduce your appetite, eating a lot of high-fiber foods (which are naturally satiating) can be a challenge

these medications are designed for chronic use, similar to blood pressure medication

Although this study provides valuable insights into the effects of GLP-1 analogs on MC4R deficiency pathology, there are several limitations that must be addressed in future studies

Hi all, been SI for about 12 months now and, apart from the occasional bit of slight pain, I've never had any issues